SAGE Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced that Jeffrey Jonas, M.D., chief executive officer, will present at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14 at 2:00 p.m. EDT at the Intercontinental Hotel in Boston.
Help employers find you! Check out all the jobs and post your resume.
